Ingevity Corp
Ingevity Corp makes specialty chemicals and engineered materials that purify, protect, and enhance industrial and consumer products. Its portfolio spans activated carbon for emissions control, pavement technologies for asphalt and road markings, and caprolactone-based specialty polymers used in coatings, elastomers, adhesives, bioplastics, and medical applications.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueActivated carbon and related materials used in emissions control and other high-specification applications.
Chemistries and additives used in asphalt paving, road technologies, and road markings.
Caprolactone and caprolactone-based specialty polymers sold into coatings, elastomers, adhesives, and medical uses.
Customers
Ingevity sells primarily to industrial customers, infrastructure-related buyers, and formulators that need performance-critical inputs. End markets include automotive OEMs and suppliers, paving contractors, government transportation agencies, chemical formulators, coatings and adhesives producers, and specialty materials customers. The company also relies on a relatively concentrated customer base in some product lines, with large customers and distributors playing an important role.
Buy activated carbon materials used in gasoline vapor emissions control systems because they must meet strict emissions standards.
Paving contractors, asphalt producers, and related infrastructure customers buy additives and technologies to improve road durability and performance.
Government agencies and private contractors buy thermoplastic and waterborne road marking systems for long-life visibility and adhesion.
Coatings, resins, elastomers, adhesives, bioplastics, and medical customers buy caprolactone-based polymers for performance properties.
Strategy
Management is simplifying the portfolio toward two core businesses: Performance Materials and Pavement Technologies. The company is also exploring strategic alternatives for Advanced Polymer Technologies and the road markings product line, aiming to focus on higher-margin, mission-critical applications with more durable demand. Capital spending and repositioning actions are being directed toward cost improvement, growth, and a more stable specialty materials mix.
Management wants a more focused business mix with stronger and more consistent profitability.
The company is targeting a more stable specialty materials portfolio with best-in-class EBITDA margins.
Ingevity is emphasizing businesses aligned with its chemistry and engineered-materials expertise.
Geography
Q1/2026Ingevity sells globally, with customers in about 70 countries and non-U.S. sales representing roughly 43% of total sales in 2025. Performance Materials is especially exposed to North America and Asia Pacific, while Advanced Polymer Technologies is served from a single manufacturing site in the U.K. Geography matters because emissions standards, vehicle mix, trade policy, and transport logistics all affect demand and profitability.
Share of the revenue the company reports by geography.
Risks
The business is exposed to customer concentration, cyclical industrial demand, and execution risk around portfolio changes. It also faces supply chain, tariff, foreign exchange, cybersecurity, and regulatory risks because it sells globally and depends on third-party logistics and critical plant services. Goodwill impairment in APT shows that weaker demand or valuation changes can quickly affect reported results.
- Supply chain and logistics disruptionImpact: HighLikelihood: High
The company depends on third-party transportation and supplier networks for raw materials and product delivery.
Exposure - Customer concentrationImpact: HighLikelihood: Medium
A small number of customers account for a meaningful share of sales in some product lines, so lost business can quickly reduce revenue.
Exposure: Ten largest customers were 41% of total sales in 2025; road markings and pavement technologies are especially concentrated.
- Strategic portfolio execution riskImpact: HighLikelihood: Medium
Planned divestitures or alternatives may not close, may be delayed, or may not deliver the expected margin improvement.
Exposure: APT and road markings are under strategic review.
- Goodwill and asset impairmentImpact: High
Weaker demand or higher discount rates can reduce fair value and trigger non-cash charges.
Exposure: APT recorded a $183.8 million goodwill impairment in 2025.
- International and FX exposureImpact: MediumLikelihood: Medium
A large share of sales is outside the U.S., creating currency, regulatory, and repatriation risk.
Exposure
Accounting
Judgemental itemsMost revenue is recognized on shipment or delivery, but a limited set of contracts is recognized over time, affecting quarterly timing.
Impact: Can shift revenue between periods and affect comparability.
APT recorded a large non-cash goodwill charge after revised demand and valuation assumptions.
Impact: Can materially reduce reported earnings without affecting cash flow.
Portfolio simplification and repositioning can create one-time costs, gains, or losses.
Impact: Affects operating income and adjusted earnings reconciliation.
International sales and operations create FX gains and losses in reported results.
Impact: Can add volatility to other income/expense and margins.
Similar listed companies
Publicly listed companies with a comparable business focus.
DuPont de Nemours, Inc.
DD · Plastic Materials, Synth Resins & Nonvulcan Elastomers
Innventure, Inc.
INVLW · Blank Checks
Enpro Inc.
NPO · Gaskets, Packg & Sealg Devices & Rubber & Plastics Hose
Avient Corporation
AVNT · Plastic Materials, Synth Resins & Nonvulcan Elastomers
Calumet, Inc.
CLMT · Petroleum Refining
Kennametal Inc
KMT · Machine Tools, Metal Cutting Types
Last updated: 24/09/2026